Literature DB >> 24102388

Effects of omalizumab in a patient with three types of chronic urticaria.

R Vieira Dos Santos1, B Locks Bidese, J Rabello de Souza, M Maurer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24102388     DOI： 10.1111/bjd.12628

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  4 in total

Review 1.  Serological evidence that activation of ubiquitous human herpesvirus-6 (HHV-6) plays a role in chronic idiopathic/spontaneous urticaria (CIU).

Authors:  D H Dreyfus
Journal:  Clin Exp Immunol       Date:  2015-11-24       Impact factor: 4.330

2.  Successful and Safe Treatment of Chronic Spontaneous Urticaria with Omalizumab in a Woman during Two Consecutive Pregnancies.

Authors:  Misbah Nasheela Ghazanfar; Simon Francis Thomsen
Journal:  Case Rep Med       Date:  2015-01-29

Review 3.  Profile of omalizumab in the treatment of chronic spontaneous urticaria.

Authors:  Moises Labrador-Horrillo; Marta Ferrer
Journal:  Drug Des Devel Ther       Date:  2015-08-25       Impact factor: 4.162

Review 4.  Urticaria: recommendations from the Italian Society of Allergology, Asthma and Clinical Immunology and the Italian Society of Allergological, Occupational and Environmental Dermatology.

Authors:  Eustachio Nettis; Caterina Foti; Marina Ambrifi; Ilaria Baiardini; Leonardo Bianchi; Alessandro Borghi; Marco Caminati; Giorgio Walter Canonica; Marco Casciaro; Laura Colli; Giselda Colombo; Monica Corazza; Antonio Cristaudo; Giulia De Feo; Ornella De Pita'; Mario Di Gioacchino; Elisabetta Di Leo; Filippo Fassio; Sebastiano Gangemi; Alessia Gatta; Katharina Hansel; Enrico Heffler; Cristoforo Incorvaia; Maddalena Napolitano; Cataldo Patruno; Silvia Peveri; Paolo Daniele Pigatto; Cristina Quecchia; Anna Radice; Giuseppe Alvise Ramirez; Paolo Romita; Franco Rongioletti; Oliviero Rossi; Eleonora Savi; Gianenrico Senna; Massimo Triggiani; Myriam Zucca; Enrico Maggi; Luca Stingeni
Journal:  Clin Mol Allergy       Date:  2020-05-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.